Debt to Capital Ratio: A measurement of a company's financial leverage, calculated as the company's long-term debt divided by its total capital. Calculated as: Total Long-Term Debt / (Total Long-Term Debt + Shareholders Equity)
Haemonetics Corporation (HAE) had Debt to Capital Ratio of 0.60 for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
$346.35M |
|
$-20.15M |
|
$148.14M |
|
$198.21M |
|
$369.38M |
|
$-23.02M |
|
$-5.37M |
|
$-28.40M |
|
$-28.40M |
|
$-20.15M |
|
$-20.15M |
|
$-20.15M |
|
$-20.15M |
|
$-23.02M |
|
$4.29M |
|
47.18M |
|
47.35M |
|
$-0.42 |
|
$-0.41 |
|
| Balance Sheet Financials | |
$834.88M |
|
$305.76M |
|
$1.56B |
|
$2.40B |
|
$282.60M |
|
$1.22B |
|
$1.32B |
|
$1.60B |
|
$796.32M |
|
$-307.70M |
|
$796.32M |
|
45.25M |
|
| Cash Flow Statement Financials | |
$293.22M |
|
$-179.55M |
|
$-178.46M |
|
$306.76M |
|
$245.44M |
|
$-61.32M |
|
$33.83M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.95 |
|
-- |
|
-- |
|
|
Debt to Capital Ratio |
0.60 |
1.54 |
|
57.23% |
|
-6.65% |
|
-6.65% |
|
-- |
|
-8.20% |
|
-5.82% |
|
$261.82M |
|
-- |
|
-- |
|
-- |
|
0.14 |
|
0.48 |
|
1.60 |
|
56.35 |
|
-2.53% |
|
6.55% |
|
-0.84% |
|
-1.00% |
|
$17.60 |
|
$5.53 |
|
$6.19 |
|